Journal Article
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
Alena Liskova; Marek Samec; Lenka Koklesova; Aranka Brockmueller; Kevin Zhai; Basma Abdellatif; Manaal Siddiqui; Kamil Biringer; Erik Kudela; Martin Pec; Laura Kate Gadanec; Miroslava Šudomová; Sherif T. S. Hassan; Anthony Zulli; Mehdi Shakibaei; Frank A. Giordano; Dietrich Büsselberg; Olga Golubnitschaja; Peter Kubatka
EPMA Journal · Vol. 12, Issue 2 · pp. 155-176 · 2021
Abstract
Cost-efficacy of currently applied treatments is an issue in overall cancer management challenging healthcare and causing tremendous economic burden to societies around the world. Consequently, complex treatment models presenting concepts of predictive diagnostics followed by targeted prevention and treatments tailored to the personal patient profiles earn global appreciation as benefiting the patient, healthcare economy, and the society at large. In this context, application of flavonoids as a spectrum of compounds and their nano-technologically created derivatives is extensively under consideration, due to their multi-faceted anti-cancer effects applicable to the overall cost-effective cancer management, primary, secondary, and even tertiary prevention. This article analyzes most recently updated data focused on the potent capacity of flavonoids to promote anti-cancer therapeutic effects and interprets all the collected research achievements in the frame-work of predictive, preventive, and personalized (3P) medicine. Main pillars considered are: - Predictable anti-neoplastic, immune-modulating, drug-sensitizing effects; - Targeted molecular pathways to improve therapeutic outcomes by increasing sensitivity of cancer cells and reversing their resistance towards currently applied therapeutic modalities.